William H. Chang - 23 Jun 2022 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Role: Director, 10%+ Owner
Signature: /s/ William Chang
Issuer symbol: ENSC
Transactions as of: 23 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 27 Jun 2022, 17:47:22 UTC
Previous filing: 04 Feb 2022
Next filing: 07 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ENSC	Common Stock						353,451	23 Jun 2022	Direct
holding	ENSC	Common Stock						2,242,189	23 Jun 2022	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENSC	Stock Option	Award		+15,000	+75%		35,000	23 Jun 2022	Common Stock	15,000	$0.4250	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 23, 2022, Mr. Chang was granted an option (the "Stock Option") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year.